← Open Payments lookup

MELISSA KROON: Open Payments

NPI 1962892240 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,590 in 68 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $817 · 2025 $1,590

Food & beverage: $1,590
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$388
Regeneron Healthcare Solutions, Inc.8$206
CSL Behring4$188
Takeda Pharmaceuticals U.S.A., Inc.9$163
GlaxoSmithKline, LLC.12$149
ARS Pharmaceuticals Operations, Inc.4$108
Grifols USA, LLC4$94
BioCryst US Sales Co., LLC3$80
Amgen Inc.3$57
Pharming Healthcare, Inc.2$40

Products named: FASENRA, DUPIXENT, TRELEGY ELLIPTA, TEZSPIRE, NEFFY, Hizentra, Prolastin-C Liquid, Andembry.

Industry payments across ID — which companies pay providers there.